GlassScriptPhysician profile
Donna M Kern
NPI 1255337747
$1,889.17
in general payments reported to CMS, 2019-2025
20 companies · $458 in 2025
The $458 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $163 · 2023: $591 · 2024: $677 · 2025: $458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,618 · Education: $85.95 · Entertainment: $22.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,617.75 |
| Education | $85.95 |
| Entertainment | $22.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $640.55 | 2022-2025 | Veozah, Myrbetriq |
| Amgen INC. | $158.65 | 2023-2025 | Evenity, Prolia |
| Sage Therapeutics, LLC | $137.42 | 2024-2025 | Zurzuvae |
| Organon LLC | $129.66 | 2023-2025 | Nexplanon, Nuvaring |
| Ethicon US, LLC | $104.29 | 2024-2025 | Stratafix, Ethicon, Harmonic |
| Pfizer INC. | $104.18 | 2023-2025 | |
| Coopersurgical, INC. | $97.04 | 2023-2025 | Paragard T 380a, Paragard T 380a |
| Millicent US INC | $88.76 | 2024-2025 | Femring, Intrarosa |
| Abbvie INC. | $86.14 | 2022-2024 | |
| Exeltis, USA INC. | $64.19 | 2024-2025 | Slynd |
| Mayne Pharma Commercial LLC | $54.51 | 2023 | |
| Hologic Sales and Service, LLC | $52.59 | 2025 | Aptima |
| Mylan Pharmaceuticals INC. | $29.02 | 2022 | |
| Daiichi Sankyo INC. | $28.95 | 2024 | Injectafer |
| Provepharm INC. | $22.60 | 2024 | Bludigo |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $21.76 | 2025 | Phexxi, Solosec, Phexx |
| Therapeuticsmd, INC. | $20.25 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.54 | 2022 | |
| Shield Therapeutics INC | $17.24 | 2023 | Accrufer |
| Merck Sharp & Dohme LLC | $13.83 | 2025 | Gardasil 9 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Kern listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.